If you‘re facing chemotherapy-induced nausea and vomiting (CINV), you know how exhausting and disruptive it can be. Persistent nausea, sudden vomiting, and loss of appetite can make everyday life feel overwhelming while your body is already coping with cancer treatment.
Managing these side effects is an important part of maintaining quality of life during chemotherapy. Some patients report that medical cannabis provides gentle support in easing nausea and vomiting, helping take the edge off constant queasiness and making it easier to eat, rest, and get through the day.
While it isn‘t a cure or a replacement for prescribed treatment, many people find it can help restore a small sense of comfort and control during a challenging time. Always speak with a qualified healthcare professional to determine whether it is an appropriate option as part of your care plan.
Did you know? In a randomised trial, adding an oral THC: CBD extract to standard antiemetics increased the rate of complete nausea and vomiting control from 8% to 24% in patients with refractory symptoms. This highlights its potential role in providing relief. For more details, see the full study in the Journal of Clinical Oncology.
Chemotherapy-induced nausea and vomiting (CINV) affects many patients and can occur shortly after treatment or last for several days. While standard anti-nausea medications help many people, some continue to experience persistent symptoms.
Medical cannabis may offer additional support by interacting with the body’s endocannabinoid system, which plays a role in regulating nausea, vomiting, and appetite. Compounds such as THC and CBD may help reduce nausea, limit vomiting episodes, and support appetite for some patients.
For those whose symptoms continue despite conventional treatments, medical cannabis may be considered as an adjunct option alongside prescribed care. Always speak with a qualified healthcare professional to ensure it fits safely within your treatment plan.
Once you express interest, the process begins with an online eligibility assessment. If suitable, our clinical partners handle everything from there, they conduct a thorough consultation to discuss your symptoms and create a tailored plan. This includes issuing any necessary approvals and arranging dispensing through reliable channels. Expect clear communication at every step, with ongoing support to adjust as needed. It’s designed to be straightforward, putting your comfort first.
We collaborate with experienced professionals to make this seamless, reassuring you that expert guidance is always available.
CINV refers to the nausea and vomiting triggered by chemotherapy drugs, often starting within hours or days of treatment. It can range from mild discomfort to severe episodes that impact eating and energy levels.
It can help by interacting with receptors in the body to ease nausea signals and reduce vomiting urges, offering support when other options fall short. Many find it helps maintain appetite, too.
When managed by specialists, it’s generally well-tolerated. Our clinical partners review your full medical history to ensure it is safe for your treatment.
Eligibility depends on factors like prior treatment responses and overall health. A quick check can determine if it’s a suitable option for you.
Possible mild effects include dizziness or drowsiness, but these are monitored closely. Benefits often outweigh them for those seeking extra nausea control.
It serves as a complementary tool that can potentially enhance relief for persistent cases. Evidence suggests it can fill gaps in standard care.
Yes, it’s typically explored for cases where guideline-recommended anti-nausea drugs (like ondansetron, dexamethasone, or others) haven’t provided enough relief. Guidelines from organisations like ASCO and NCCN recognise certain cannabinoid-based options for breakthrough or persistent symptoms, focusing on adding support rather than replacing your current plan.
Check your eligibility for medical cannabis and discover supportive options to help ease nausea and vomiting during chemotherapy.